Application of Genetically-Engineered Anti-CEA Antibodies for Potential Immunotherapy of Colorectal Cancer
Data up to Jan 2025
Total Citations Per Year
Abstract
References (30)
Reshaping human antibodies for therapy
1988 • 1,555 citations
Assembly of combinatorial antibody libraries on phage surfaces: the gene III site.
1991 • 1,178 citations
REMISSION INDUCTION IN NON-HODGKIN LYMPHOMA WITH RESHAPED HUMAN MONOCLONAL ANTIBODY CAMPATH-1H
1988 • 703 citations
Comparison of the effector functions of human immunoglobulins using a matched set of chimeric antibodies.
1987 • 615 citations
Mouse/human chimeric monoclonal antibody in man: kinetics and immune response.
1989 • 526 citations
A recombinant immunotoxin consisting of two antibody variable domains fused to Pseudomonas exotoxin
1989 • 420 citations
Identification of an Antigen from Normal Human Tissue That Crossreacts with the Carcinoembryonic Antigen
1972 • 376 citations
Cea-related antigens: Molecular biology and clinical significance
1985 • 268 citations
Humanization of a mouse monoclonal antibody by CDR–grafting: the importance of framework residues on loop conformation
1991 • 193 citations
Detection of colorectal carcinoma by emission-computerized tomography after injection of 123I-labeled Fab or F(ab')2 fragments from monoclonal anti-carcinoembryonic antigen antibodies.
1986 • 191 citations
Transfectomas Provide Novel Chimeric Antibodies
1985 • 184 citations
Enhancement of antibody-dependent cytotoxicity with a chimeric anti-GD2 antibody.
1990 • 179 citations
The immunogenicity of chimeric antibodies.
1989 • 176 citations
Monoclonal antibodies identify a cea crossreacting antigen of 95 kD (NCA‐95) distinct in antigenicity and tissue distribution from the previously described NCA of 55 kD
1984 • 151 citations
Antibody redesign by chain shuffling from random combinatorial immunoglobulin libraries.
1991 • 144 citations
Generation of an antibody with enhanced affinity and specificity for its antigen by protein engineering
1987 • 136 citations
Humanized antibodies for antiviral therapy.
1991 • 126 citations
Clinical value of immunoscintigraphy in colorectal carcinoma patients: a prospective study.
1989 • 103 citations
Phase I trial of murine monoclonal antibody L6 in breast, colon, ovarian, and lung cancer.
1990 • 102 citations
Secretion and in vivo folding of the Fab fragment of the antibody McPC603 in Escherichia coli: influence of disulphides and cis-prolines
1991 • 91 citations
Serum half-life and tumor localization of a chimeric antibody deleted of the CH2 domain and directed against the disialoganglioside GD2.
1990 • 83 citations
Radioimmunotherapy of human colon carcinoma by 131I‐labelled monoclonal anti‐cea antibodies in a nude mouse model
1988 • 72 citations
Imaging and therapy with monoclonal antibodies in non-hematopoietic tumors
1991 • 51 citations
DEVELOPMENT OF ANTI-IDIOTYPIC ANTIBODIES AGAINST TUMOUR ANTIGENS AND AUTOANTIGENS IN OVARIAN CANCER PATIENTS TREATED INTRAPERITONEALLY WITH MOUSE MONOCLONAL ANTIBODIES
1988 • 48 citations
Generation of a recombinant mouse‐human chimaeric monoclonal antibody directed against human carcinoembryonic antigen
1989 • 41 citations
Radioimmuno positron emission tomography with monoclonal antibodies
1991 • 40 citations
Different behaviour of mouse‐human chimeric antibody F(ab')2 fragments of IgG1, IgG2 and IgG4 sub‐class in vivo
1992 • 26 citations
Bone marrow dosimetry in rats using direct tissue counting after injection of radio-iodinated intact monoclonal antibodies or F(ab')2 fragments.
1991 • 21 citations
Monoclonal antibodies in cancer therapy
1990 • 16 citations
Chimeric univalent antibodies for treating lymphoid malignancies
1984 • 11 citations